Search Results - "Boice, Jillian"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Trop-2 mRNA expression and association with clinical outcomes with sacituzumab govitecan (SG) in patients with HR+/HER2– metastatic breast cancer (mBC): Biomarker results from the phase 3 TROPiCS-02 study

    Trop-2 mRNA expression and association with clinical outcomes with sacituzumab govitecan (SG) in patients with HR+/HER2– metastatic breast cancer (mBC): Biomarker results from the phase 3 TROPiCS-02 study by Bardia, Aditya, Rugo, Hope S., Cortés, Javier, Tolaney, Sara M., Schmid, Peter, Motwani, Monica, Yoon, Oh Kyu, Boice, Jillian, Zhuo, Luting, Marmé, Frederik

    Published in Journal of clinical oncology (01-06-2023)
    “…1082 Background: SG is a Trop-2–directed antibody-drug conjugate approved in multiple countries for patients with metastatic triple-negative breast cancer who…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1

    Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1 by Riddler, Sharon A, Para, Michael, Benson, Constance A, Mills, Anthony, Ramgopal, Moti, DeJesus, Edwin, Brinson, Cynthia, Cyktor, Joshua, Jacobs, Jana, Koontz, Dianna, Mellors, John W, Laird, Gregory M, Wrin, Terri, Patel, Heena, Guo, Susan, Wallin, Jeffrey, Boice, Jillian, Zhang, Liao, Humeniuk, Rita, Begley, Rebecca, German, Polina, Graham, Hiba, Geleziunas, Romas, Brainard, Diana M, SenGupta, Devi

    Published in Clinical infectious diseases (01-06-2021)
    “…Abstract Background Treatment with vesatolimod, an investigational, oral, toll-like receptor 7 (TLR7) agonist, leads to sustained viral remission in some…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Abstract 4392: Expression landscape of trophoblast cell surface antigen 2 (Trop-2) in breast cancer

    Abstract 4392: Expression landscape of trophoblast cell surface antigen 2 (Trop-2) in breast cancer by Song, Kai, Yoon, Oh Kyu, Zhuo, Luting, Elboudwarej, Emon, Li, Biao, Boice, Jillian, Pan, Yang, Phan, See, Motwani, Monica

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Background: Antibody-drug conjugates (ADCs) are novel agents linking potent payloads to antibodies targeting antigen-expressing tumors. Sacituzumab…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Phase 1/2 study of durvalumab and tremelimumab as monotherapy and in combination in patients with unresectable hepatocellular carcinoma (HCC)

    Phase 1/2 study of durvalumab and tremelimumab as monotherapy and in combination in patients with unresectable hepatocellular carcinoma (HCC) by Abou-Alfa, Ghassan K., Sangro, Bruno, Morse, Michael, Zhu, Andrew X., Kim, Richard D., Cheng, Ann-Lii, Kudo, Masatoshi, Kang, Yoon-Koo, Chan, Stephen L., Antal, Joyce, Boice, Jillian, Xiao, Feng, Morris, Shannon R., Bendell, Johanna

    Published in Journal of clinical oncology (20-05-2016)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: